GPX4 and nasopharyngeal carcinoma: However, knockdown of neither GPX4 nor TAK1 combined with GPX4 overexpression had a significant effect on the MAPK-p38 pathway, which suggests that the two branches of MAPK may be regulated differently in EBV-positive NPC cells.